European healthcare stocks jumped on Wednesday, mirroring moves in the United States, propelled by a deal between Pfizer and President Donald Trump to lower prescription drug prices in the Medicaid programme in exchange for tariff relief. The agreement, seen as less punishing than some within the industry had feared, gives hard-hit global drugmakers a degree…
Midweek Movers: We had another very nice trading day on Wednesday, continuing our solid run for the week. Our premarket report, contained a trio of possible plays, and we weren’t disappointed in the results they logged on the session. Our daily interests for Wednesday consisted of the GSK Weekly $38 Calls, the VRT Weekly $150 Calls,…
Tuesday’s Movers: We fared pretty well yesterday, maintaining this trading week’s respectable start. After including four potential plays in our premarket report, we were met with some nice performances which provided intraday opportunity for traders, and kept up the solid results we’ve seen this week. Our targets for Monday were the SPOT Weekly $657.50-652.50 Puts, the MRK Weekly…
Moderna pushed back its break-even goal by two years on Thursday as it delayed the timeline for developing several key products and predicted 2025 sales below its forecast for the current year, sending its shares closer to a four-year low. Shares of the vaccine maker tumbled 17.1% to $65.88 at midday. The company expects sales…